Back to results
US 12,605,378 B2Granted
Small therapeutic molecules capable of inhibiting the catalytic activity of the main protease enzyme of SARS-CoV-2
OwnerÖzge Sensoy, Metehan Ilter +1inventors
InventorsÖzge Sensoy, Metehan Ilter, Hanife Pekel
Life of this patent
Estimating the term…
Abstract
The present invention relates to molecules represented with Formula (I), Formula (II), and Formula (III) and the use of these molecules in the treatment of SARS-CoV-2.
Claims2
A pharmaceutical composition comprising
- i) at least one compound selected from Formula I, Formula II, Formula III, and salts, hydrates, solvates, polymorphs, optical isomers, geometric isomers, enantiomers, diastereomers thereof for use in the treatment of SARS-COV-2
- ii) at least one pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.